RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Clinical trials for RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for patients who have run out of options
Disease control Recruiting nowThis early-stage study is testing the safety and side effects of an experimental drug called trichostatin A in adults with blood cancers that have returned or stopped responding to standard treatments. The main goal is to find the highest dose patients can tolerate without severe…
Matched conditions: RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug trial offers hope for Tough-to-Treat blood cancers
Disease control Recruiting nowThis study is testing a new drug called QLS2309 for adults with advanced blood cancers that have returned or stopped responding to other treatments. The main goals are to find a safe dose and see how the body handles the drug. Researchers will also look for early signs that the d…
Matched conditions: RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC